Get the Stockscreener App
4.04
2.88%
-0.12
Bionano Genomics Inc stock is traded at $4.04, with a volume of 88,026.
It is down -2.88% in the last 24 hours and down -23.77% over the past month.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.
See More
Previous Close:
$4.16
Open:
$4.24
24h Volume:
88,026
Relative Volume:
0.45
Market Cap:
$11.11M
Revenue:
$36.12M
Net Income/Loss:
$-232.49M
P/E Ratio:
-0.2272
EPS:
-17.78
Net Cash Flow:
$-126.87M
1W Performance:
-18.55%
1M Performance:
-23.77%
6M Performance:
-85.51%
1Y Performance:
-94.61%
1-Day Range:
$3.9451
$4.39
1-Week Range:
$3.9451
$4.92
52-Week Range:
$3.9451
$76.52
Bionano Genomics Inc Stock (BNGO) Company Profile
Name
Bionano Genomics Inc
Sector
Industry
Phone
(858) 888-7600
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA
Compare BNGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BNGO
Bionano Genomics Inc
|
4.06 | 11.11M | 36.12M | -232.49M | -126.87M | -17.78 |
|
ISRG
Intuitive Surgical Inc
|
580.49 | 205.74B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.45 | 65.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
94.91 | 46.26B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
235.25 | 34.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
92.42 | 18.19B | 3.90B | 392.30M | 288.10M | 1.95 |
Bionano Genomics Inc Stock (BNGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-15-24 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Sep-10-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Dec-12-22 | Resumed | BTIG Research | Buy |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Jun-16-21 | Initiated | BTIG Research | Buy |
| Sep-24-20 | Initiated | Ladenburg Thalmann | Buy |
| Apr-08-20 | Initiated | Oppenheimer | Outperform |
View All
Bionano Genomics Inc Stock (BNGO) Latest News
Bionano Genomics Inc expected to post a loss of $6.00 a shareEarnings Preview - TradingView
BNGO stock touches 52-week low at $4.75 amid market challenges - Investing.com
BNGO stock touches 52-week low at $4.75 amid market challenges By Investing.com - Investing.com South Africa
When the Price of (BNGO) Talks, People Listen - Stock Traders Daily
BioNano Genomics Executes Significant Reverse Stock Split - MSN
Bionano Genomics announces 1-for-60 reverse stock split - MSN
Bionano Genomics ends sales agreement with Cowen - MSN
Slammed 62% Bionano Genomics, Inc. (NASDAQ:BNGO) Screens Well Here But There Might Be A Catch - Simply Wall St
Bionano Genomics ends sales agreement with Cowen By Investing.com - Investing.com South Africa
BioNano Genomics Ends Sales Agreement with Cowen - TipRanks
Bionano Genomics IncOn February 4, Terminates Sales Agreement With Cowen Effective February 14, 2025 - Marketscreener.com
Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline - MSN
Bionano Announces Effective Date of Reverse Stock Split - EIN News
Bionano Genomics stock hits 52-week low at $4.9 amid sharp decline By Investing.com - Investing.com South Africa
Bionano Genomics, Inc. (NASDAQ:BNGO) Sees Large Decrease in Short Interest - MarketBeat
Bionano Genomics (NASDAQ:BNGO) Stock Price Up 5.5%Time to Buy? - MarketBeat
Page 16 | BIONANO GENOM. CP DL-0001 Trade Ideas — BER:2Y3 - TradingView
Bionano Genomics (NASDAQ:BNGO) Shares Gap DownWhat's Next? - MarketBeat
Bionano Genomics (NASDAQ:BNGO) Hits New 52-Week LowHere's Why - MarketBeat
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges - MSN
Bionano Genomics stock hits 52-week low at $0.17 amid market challenges By Investing.com - Investing.com South Africa
Bionano Genomics stock slips on reverse stock split (BNGO) - Seeking Alpha
Bionano Genomics Announces Major 1-for-60 Reverse Stock Split, Set for January 24 | BNGO Stock News - StockTitan
Bionano Genomics shareholders approve stock issuance and reverse split - Investing.com India
Bionano Genomics shareholders approve stock issuance and reverse split By Investing.com - Investing.com UK
Bionano Genomics, Inc. Announces Use of Ogm in Preimplantation Genetic Testing as Part of Successful Live Birth to A Couple Experiencing Recurrent Pregnancy Loss - Marketscreener.com
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss - The Manila Times
Bionano's Genome Mapping Tech Enables Breakthrough in IVF Success After Recurrent Pregnancy Loss - StockTitan
Bionano reports Q4 preliminary revenue in range of $7.9 million to $8.1 million - MSN
Bionano Genomics, Inc. Provides Earnings Guidance for the Fourth Quarter and for Full Year 2024 - Marketscreener.com
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - The Manila Times
Bionano Genomics, Inc. (NASDAQ:BNGO) Position Raised by Geode Capital Management LLC - Defense World
Bionano Genomics Announces $10 Million Registered Direct OfferingOn January 3, 2025, Bionano Genomics, Inc. (NASDAQ: BNGO) disclosed a definitive agreement with institutional investors for a registered direct offering. The offering involves the purch - Defense World
What You Didn’t Know About Bionano Genomics Inc (NASDAQ: BNGO) This Week - Stocks Register
BioNano Genomics Announces $10 Million Direct Offering - Yahoo Finance
Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - The Manila Times
Bionano announces registered direct offering - Medical Buyer
Bionano Genomics Restructures Debt Through Settlement Agreement and AmendmentSAN DIEGO, December 31, 2024 – Bionano Genomics, Inc. (Nasdaq: BNGO) has announced the execution of a settlement agreement and amendment concerning its senio - Defense World
Bionano stock rallies 19% on ATM direct offering - MSN
Bionano Genomics Inc Stock (BNGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.44%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):